Heart Failure - Systolic Dysfunction [update 2019]
Heart Failure - Systolic Dysfunction [update 2019] is organized by University of Michigan Health System (UMHS).
Release Date: Wed, 1/1/20
Termination Date: Fri, 12/31/20
• AMA PRA Category 1: 1.00
• Participation: 1.00
Over the past decade, the understanding of HF has changed dramatically. The most common cause of HF remains an ischemic insult. This insult initiates a cascade of events mediated by neurohormonal influences that adversely affect the heart. Numerous pharmacologic and lifestyle interventions can improve mortality. The availability of so many treatments has resulted in confusion about how and in whom to initiate and titrate therapy, resulting in variation in the management of this condition and under use of medications that have been proven effective.
Health care systems have targeted HF as a medical condition needing better disease-based management because of its prevalence and its management costs. Treatment guidelines have evolved to improve the standardization of care using evidence-based approaches. This guideline-based, self-study activity provides practical guidance to clinicians about managing heart failure due to systolic dysfunction. A framework of symptom severity guides pharmacologic treatment of these patients.
Participants in this CME activity will understand and be able to implement evidence-based cost-effective clinical strategies for the diagnosis and treatment of heart failure in adults.
- CME : 1
This self-study activity is appropriate for primary care clinicians and other health care providers who diagnosis and treat heart failure in adults.
Number of Health Care Professionals Registered: 0 Number
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine